Salarius Pharmaceuticals (SLRX)
(Delayed Data from NSDQ)
$0.58 USD
-0.03 (-4.92%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.60 +0.02 (3.45%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Salarius Pharmaceuticals, Inc. has a market cap of $1.30M, which represents its share price of $0.61 multiplied by its outstanding shares number of 2.13M. As a small-cap company, SLRX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SLRX 0.58 -0.03(-4.92%)
Will SLRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLRX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SLRX
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings